CIK 0001817229
- Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811591163
- Phone
- +1 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Grant or award Chief Financial Officer acquired 52,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 38,974,101 shares
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,334 shares at $1.25 ($12,918)
- 4 Grant or award Director acquired 16,897,159 shares (grant or award)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 875 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President of Finance gave up 206 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 999 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President of Finance gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 986 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,146 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,751 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 5,576 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 12,657 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President of Finance gave up 4,951 shares (to pay taxes)
Page 5 of 11 · 212 filings